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Background: Mild cognitive impairment (MCI), defined as a transitional zone between normal cognition and
dementia, requires a battery of formal neuropsychological tests administered by a trained rater for its diagnosis. The
objective of this study was to develop a screening tool for MCI.
Methods: One hundred ninety seven cognitively normal controls (NC), one hundred sixteen patients with amnestic
MCI –single domain (aMCI-sd), one hundred ninety five patients with amnestic MCI-multiple domain (aMCI-md),
and two hundred twenty eight patients with mild Alzheimer’s disease (AD) were evaluated by comprehensive
neuropsychological tests and by the Memory and Executive Screening (MES).
Results: Correlation analysis showed that the three indicators of the MES were significantly negatively related with
age (P<0.05), yet not related with education (P>0.05). There was no ceiling or floor effect. Test completion averaged
seven minutes (421.14±168.31 seconds). The receiver operating characteristics (ROC) analyses performed on the
aMCI-sd group yielded 0.89 for the area under the curve (AUC) (95% CI, 0.85–0.92) for the MES-total score, with
sensitivity of 0.795 and specificity of 0.828. There was 81% correct classification rate when the cut-off was set at less
than 75. Meanwhile, the aMCI-md group yielded 0.95 for the AUC (95% CI, 0.93–0.97) for the MES-total score, with
sensitivity of 0.87 and specificity of 0.91, and 90% correct classification rate when the cut-off was set at less than 72.
Conclusion: The MES, minimally time-consuming, may be a valid and easily administered cognitive screening tool
with high sensitivity and specificity for aMCI, with single or multiple domain impairment.
Keywords: Mild cognitive impairment (MCI), Amnestic MCI-single domain (aMCI-sd), Amnestic MCI-multiple domain
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In China, the elderly above sixty years of age account for
13.26% of the population, and aging and Alzheimer’s dis-
ease (AD) have been significant public health problems
[1]. Mild cognitive impairment (MCI), defined as a tran-
sitional zone between normal cognition and dementia
[2], may be a target population for dementia early identi-
fication and intervention. MCI may occur in 15% of eld-
erly patients [3]. Because of these large numbers and the
absence of specific physiological markers, easier and
earlier detection of cognitive impairment in the elderly* Correspondence: profzhong@sina.com
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reproduction in any medium, provided the orpopulation at minimal cost of time, resources, and
expenses is increasingly important.
There are a variety of shorter or longer screening
methods for MCI and mild dementia currently, such as
the Seven minute neurocognitive screening battery(7MS)
[4], the Memory Impairment Screen (MIS) [5], the clock
drawing test [6], the cube-copying test [7], the DemTect
[8], the AB Cognitive Screen (ABCS) [9], the AD8 [10],
the Montreal Cognitive Assessment (MoCA) [11], the
Short Cognitive Performance Test [12], the Adden-
brooke’s Cognitive Examination Revised(ACE-R) [13],
the Memory Alteration Test (M@T) [14], and the Mem-
ory Orientation Screening Test(MOST) [15]. There are
differences among these tests for cognitive domain and
item coverage, completion rate, administration times,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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values. At present, no one screening test used for MCI is
acknowledged internationally in the way that the Mini-
Mental State Examination (MMSE) is for dementia [16].
Time length and complexity are the major concerns of
brief tests. We found that the tests currently used, such
as MoCA and ACE-R, take more than 10 minutes. Al-
though some other non-comprehensive tests, e.g., the
Clock drawing test and MIS, take a short time to admin-
ister, the simple scoring and administration methods
without the necessity for training, their sensitivity and
specificity in detecting MCI were relatively low [17]. AD,
Frontotemporal lobar degeneration (FTLD) and vascular
dementia (VaD) are the major types of dementia syn-
dromes [18,19]. Memory impairment is often the earliest
symptom of AD and executive function impairments are
often the earliest symptoms of FTLD and VaD [20,21].
Therefore, more than orientation, attention, language
and visuospatial function, tests focusing on memory and
executive function could be the most sensitive for
detecting early stages of MCI. As most tests are educa-
tion-related, their application in populations with little
education remains controversial. Tests independent of
pencil and paper and without requirements for reading
and writing could decrease this cultural bias.
Our goal was to develop a test that could be applied to
detect MCI. Ideally, it could be administered in less than
10 minutes by a variety of clinical staff, be reliably and
easily scored without the need of a complex algorithm
or computer program, and be readily accepted by
patients to detect the early stage of MCI. The test would
be especially practical for those patients who require fur-
ther evaluation or prompt initiation of medication and
supportive services. No specialized testing materials
would be required and it could be easily adapted for
non-Chinese-speaking elderly. In this study, a brief test
named Memory and Executive Screening was developed
in which the instruction and content were acceptable for
illiterate and low-educated people. In addition, this test
didn’t require the participants to write. Therefore, we




A total of 796 (n=796) participants were recruited, in-
cluding 197 (n=197) cognitively normal controls (NC),
116 patients (n=116) with amnestic MCI-single domain
(aMCI-sd), 195 patients (n=195) with amnestic MCI-
multiple domain (aMCI-md), and 228 patients (n=228)
with mild Alzheimer’s disease (AD).
We recruited the NCs using cluster sampling in Jin-
gansi Community, Shanghai, China from Jan 2009 to Jun
2009. The inclusion criteria for NC group were: agebetween 50 and 90; cognitively normal, based on the ab-
sence of significant impairment in cognitive functions or
activities of daily living (ADL), no memory complaints
or memory difficulties (verified by an informant); Clin-
ical Dementia Rating (CDR) = 0 [22]; score of Hamilton
depression rating scale [23] less than or equal to 12 on
the 17-item scale in the preceding 2 weeks; and adequate
visual and auditory acuity to allow cognitive testing. Par-
ticipants with any significant neurologic disease and psy-
chiatric disorders/psychotic features were excluded.
All patients were recruited from the Memory Clinic,
Huashan Hospital, from Jun 2009 to Oct 2011.They
underwent laboratory screening and cranial CT/MRI
scan, with no clinically significant abnormalities in
vitamin B12, folic acid, thyroid function (free triiodo-
thyronine-FT3, free tetraiodothyronine-FT4, thyroid sti-
mulating hormone-TSH, rapid plasma reagin-RPR, or
treponema pallidum particle agglutination -TPPA.
Three hundred and eleven (n=311) participants were
diagnosed as amnestic MCI according to the Peterson
criteria [24]: (1) memory complaints and memory diffi-
culties which are verified by an informant; (2) symptoms
lasting more than 3 months; (3) total score of the Mini-
mental state examination-Chinese version (CMMSE)
[25] ≥ the cut-off score adjusted for education; objective
memory impairment documented by scoring below the
age- and education-adjusted cutoff on tests of episodic
memory, including the Auditory Verbal Learning Test
[26]; preserved basic ADL/minimal impairment in com-
plex instrumental functions; (4) etiology unknown; (5)
normal sense of hearing and sight; (6) has not met diag-
nostic criteria of dementia based on those of the Na-
tional Institute of Neurological and Communicative
Disorders and Stroke and the Alzheimer’s Disease and
Related Disorders Association (NINCDS-ADRDA) [27].
Patients with aMCI were then differentiated as aMCI-sd
and aMCI-md according to the impaired cognitive
domains [28].
The mild AD patients (n=228) met the following cri-
teria: Patients were diagnosed as probable AD according
to the NINCDS-ADRDA; CDR=1; onset age ≥ 50 yrs; no
obvious medical, neurological or psychiatric diseases or
psychological dysfunction including anxiety and depres-
sion within the previous one month; no visual or audi-
tory deficit.
Neurologists were in charge of the classification of
normal, MCI and AD, taking the medical history, neuro-
psychological assessment and neuroimaging results into
consideration.
The study was approved by the Huashan Hospital
Foundation Ethical Committee, and each subject signed
an informed consent.
For the Memory and Executive Screening (MES), see
Appendix 1. There are three indicators for cognition
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remembered three times and free delay recalled two
times. The summation of the five recall scores is MES-
5R. This reflects instant and delayed memory and learn-
ing ability. The four subtests of the MES-EX are the
category fluency test, the sequential movement tasks,
conflicting instructions task and Go/No-go task. This
reflects executive function. The total possible score
is one hundred, with fifty each for the MES-5R and
MES-EX.
Measures
Participants were given neuropsychological tests by a
trained rater who was blind to diagnosis. Except for the
MMSE and MES, a comprehensive neuropsychological
battery that included memory, language, attention, ex-
ecutive function and visuospatial ability was used. The
tests were as follows: the Auditory Verbal Learning Test
(AVLT) [29], the Rey-Osterrieth Complex Figure Test
(CFT) [30], the Boston Naming Test (BNT; the 30-item
version) [31], the Animal Fluency Test (AFT) [32], the
Symbol Digit Modalities Test(SDMT) [33], the Trail
Making Test-A and B (TMT-A, TMT-B) [34], the Stroop
Color-Word Test (SCWT) [33], the Similarity test [35],
the Clock-drawing test [6], the Clinical Dementia Rating
(CDR) [22] and Center for Epidemiologic Studies De-
pression scale (CESD) [36]. All tests have been proven
to have a good reliability and validity with those of a
Chinese cultural background. Each patient with MCI or
AD received a CT/MRI examination.
Statistical analysis
Chi-square analysis was adopted for ordinal data. Overall
differences among the four groups (aMCI-sd, aMCI-md,
mild AD and NC groups) were assessed with one-way
analysis of variance (ANOVA). Post hoc pairwise com-
parisons between groups were assessed using the LSD
test. The level of significance was set at α = .05. Pearson
correlation was used to evaluate the relationship ana-
lysis. Receiver operating characteristic curves were used
to assess the sensitivity, specificity and cut-off score.
Associations of the MMSE and MES with the dichotom-
ous clinical diagnoses were examined by using ROCs.
The area under the ROC curves (AUC) was used as an
overall index of performance of the screening tests. The
AUCs and their standard errors were calculated using
the method of Hanley and McNeil [37].
Results
Baseline characteristics
The comparison of general information and standard
neuropsychological tests among the four groups is pre-
sented in Table 1. There were no significant differences
in age, sex and education among the four groups(P>0.05).No significant differences were seen for MMSE
between the aMCI-sd and aMCI-md groups, for delayed
memory between the aMCI-md and mild AD, or for
BNT, CFT-Copy, CWT-CR and TMT-part B between
the aMCI-sd and NC groups (p>0.05). The testing con-
firmed the clinical features of patients with aMCI-sd and
aMCI-md.
Essential features of MES
Demography factors and MES
Correlation analyses were carried out for the NCs. Age
was significantly related with the three indicators of
MES (p<0.05). When a person was older, s/he obtained a
lower score. According to age, four subgroups were
determined for NCs. There were 23 persons aged 50–59,
87 aged 60–69, 74 aged 70 –79, and 13 aged 80–89. The
total scores for the MES were 84.0, 83.0, 80.5, and 77.9,
respectively. There were distinct differences among sub-
groups (F=2.972, P=0.033), yet education level had no
relationship with the test (p>0.05). No differences were
found between male and female in the total scores and
factor scores of the MES. In contrast, age and education
significantly correlated with the MMSE score (correl-
ation coefficients were −0.233 and 0.304, respectively,
p<0.01).
The relationship of MES-5R, MES-EX and MES
Correlation analyses were done for all participants. The
correlation coefficients were 0.892 for MES-5R and MES
total score (p<0.01), 0.882 for MES-EX and MES total
score (p<0.01), and 0.573 for MES-5R and MES-EX
(p<0.01).
The relationship of MES and standard psychological tests
The coefficients were 0.663 for MES-5R and AVLT-total
score (p<0.01), 0.523 for MES-5R and CFT-delay recall,
0.554 for MES-EX and the SCWT- interference effects,
and 0.381for MES-EX and time scores of the TMT-part
B (p<0.01).
Ceiling and floor effects
For NCs, the proportions obtaining the maximum score
on the MES-5R, MES-EX and MES total were 4.1%,
20.3% and 2.5%. For mild AD subjects, 2.2% scored zero
in the subtest of MES-5R, but no one scored zero in the
MES-EX and MES-total. The scores of MCI patients
were intermediate between the NC and AD groups. This
demonstrated that there were no obvious ceiling and
floor effects.
Test administration times
The average administration times were 421.14±168.31
seconds, about seven minutes, for the MES test, and
Table 1 Demographics and Standardized Neuropsychological Tests for the 4 Groups [ mean (standard deviation)]
Index NC (n=197) aMCI-sd (n=116) aMCI-md (n=195) AD (n=228) F(P)
Age 68.84 (7.70) 70.04 (9.13) 70.27 (8.75) 70.19 (9.17) 1.164 (0.323)
Education 9.42 (5.17) 9.66 (4.85) 9.14 (5.19) 9.21 (4.98) 0.313 (0.816)
Sex1 110:89 53:63 96:100 129:102 1.813 (0.143)
MMSE 27.05 (2.11) 25.59 (2.61) ** 25.17 (2.72) $$ 19.09 (2.58)## 414.451 (<0.001)
AVLT-delayed recall(M=12) 5.30 (2.01) 1.19 (1.31) ††** 1.01 (1.27) 0.27 (0.83)## 176.26 7(<0.001)
BNT(M=30) 23.56 (4.55) 23.56(4.75) †† 21.08 (3.51) $$ 18.01 (5.47)## 21.787 (<0.001)
SDMT 41.40 (11.98) 37.40 (10.57) †† 29.37 (13.48) $$ 20.16 (11.89)## 33.441 (<0.001)
CFT-Copy(M=36) 33.22 (3.42) 32.86 (3.13) † 29.73 (7.54) $ 24.74 (9.31)## 22.917(<0.001)
CFT-delayed recall(M=36) 15.47 (5.55) 11.69 (7.39) † 9.07 (5.58) $$ 4.15 (3.34) ## 38.909(<0.001)
CWT-CR(M=50) 45.73 (3.94) 42.96 (9.61) † 38.70 (10.43) $$ 29.50 (13.68)## 33.370(<0.001)
TMT-partA(s) 55.08 (20.78) 64.43 (25.25) †† 84.66 (36.57) $$ 118.30 (48.31) ## 36.214(<0.001)
TMT-part B(s) 155.89 (63.99) 172.08 (68.55)†† 250.37(107.90)$$ 331.28(131.65)## 32.921(<0.001)
CESD 11.43(2.24) 13.67(3.12) 10.30(2.79) 10.64(3.06) 1.329(0.266)
Comparison between NC group and aMCI-sd group is marked behind ‘aMCI-sd group’; ** P<0.01.
Comparison between aMCI-sd group and aMCI-md group is marked behind ‘aMCI-sd group’; † P<0.05; †† P<0.01.
Comparison between aMCI-md group and AD group is marked behind ‘aMCI-md group’; $ P<0.05; $$ P<0.01.
Comparison between NC group and AD group is marked behind ‘AD group’. # P<0.05; ## P<0.01.
AVLT: Auditory Verbal Learning Test; BNT: Boston Naming Test; SDMT: Symbol Digit Modalities Test; CFT: Rey-Osterrieth Complex Figure Test; CWT-CR: Card C right
of Stroop Color-Word Test; TMT: Trail Making Test; CESD: Center for Epidemiologic Studies Depression.
1 chi-square test, M=maximum.
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MMSE.
Completion rate
For the elderly from the community who were the NCs,
4% rejected finishing the cognitive testing, but when
subjects were willing to finish the MMSE, they also fin-
ished the MES. The outpatients were examined by a
trained rater in the neuropsychological department. The
completion rate of the patients with MCI and mild AD
was 100%.
Reliability
The data were collected twice from a subsample of 30
participants (patients and controls) tested, 29.1(5.8) days
apart on average. The mean change in MES total scores
from the first to the second evaluation was 4.7(5.8)
points, and the correlation among the scores of the 5
briefly trained raters evaluations was high (Pearson r =
0.92, P<0.001).Table 2 Comparisons of MES score among the four groups
Index NC (n=197) aMCI-sd (n=116) a
MES-5R 36.64 (7.66) 24.67 (6.72) ††** 2
MES-EX 45.60 (3.89) 41.81 (5.07) ††** 3
MES total 82.25 (9.40) 66.49 (8.16) ††** 5
Comparison between NC group and aMCI-sd group is marked behind ‘aMCI-sd grou
Comparison between aMCI-sd group and aMCI-md group is marked behind ‘aMCI-s
Comparison between aMCI-md group and AD group is marked behind ‘aMCI-md gr
Comparison between NC group and AD group is marked behind ‘AD group’. ## P<0Comparisons of MES scores among four groups
The scores of the four groups are presented in Table 2.
The results of patients with aMCI were intermediate be-
tween the NC and AD groups. For the aMCI-sd group,
the memory functions declined obviously, while the de-
crease of executive function was relatively slight. For the
aMCI-md group, the executive function was inferior to
that of the aMCI-sd group, as was memory function. In
general, the cognitive deficits of the aMCI-md group
were more serious than those of the aMCI-sd group.
The pattern of cognitive deficits for aMCI-md was simi-
lar to that of mild AD.
ROC analyses of MES and MMSE
As shown in Table 3, according to the area of the ROCs,
the MES total score was more helpful for aMCI-sd and
aMCI-md discrimination than was the MMSE. The
MES-5R identified aMCI-sd better than the MES-EX,
whereas for aMCI-md, the MES-EX was superior to the
MES-5R.MCI-md (n=195) AD (n=228) F(P)
1.28 (8.62) $$ 13.59 (6.71)## 339.125 (<0.001)
5.05 (6.99) $$ 24.36 (9.98)## 340.003(<0.001)
6.33 (11.30) $$ 37.96 (12.20)## 628.306(<0.001)
p’; ** P<0.01.
d group’; †† P<0.01.
oup’; $$ P<0.01.
.01.
Table 3 ROC analysis of MMSE and MES











NC vs aMCI-sd MMSET .669 .606–.732 ≤27 67.7 61.2 65.2
MEST .893 .858–.928 ≤75 79.5 82.8 80.8
NC vs aMCI-md MMSET .715 .663–.767 ≤27 67.7 70.0 68.9
MEST .956 .938–.974 ≤72 87.8 91.3 89.5
NC vs AD MMSET .985 .976–.994 ≤24 91.8 98.2 95.3
MEST .998 .996–1.000 ≤62 99.0 97.8 98.4
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the range for patients with aMCI. Subjects exceeding 75
were usually considered as NCs, and subjects scoring
less than 62 may be suspected as having dementia. In
the range 75–62, the lower the score, the more likely the
diagnosis of aMCI-md, while the higher the score, the
more likely the diagnosis of aMCI-sd.
The ROC analyses performed on the aMCI-sd group
yielded 0.89 for the area under the curve (AUC) (95%
CI, 0.85–0.92) for the MES-total score, with sensitivity
of 0.795 and specificity of 0.828 , and 81% correct classi-
fication rate when the cut-off was less than 75. The
MMSE had 0.66 AUC (95% CI, 0.60–0.73), with sensitiv-
ity of 0.67 and specificity of 0.61, and 65% correct classi-
fication rate when the cut-off was less than 28. The
AUC of the MES-total score was significantly higher
than that of the MMSE (Z=6.948,P < 0.0001). The ROC
graphs are presented in Figure 1.
The ROC analyses performed on the aMCI-md group
yielded 0.95 for the area under the curve (AUC) (95%Figure 1 ROC curve of NC vs aMCIsd.CI, 0.93–0.97) for the MES-total score, with sensitivity
of 0.87 and specificity of 0.91, and 90% correct classifica-
tion rate when the cut-off was less than 72. The MMSE
had 0.71 AUC (95% CI, 0.66–0.76), with sensitivity of
0.67 and specificity of 0.70, and 69% correct classifica-
tion rate when the cut-off was less than 28. The AUC of
the MES-total score is significantly higher than that of
the MMSE (Z=9.732,P < 0.0001). The ROC graphs are
presented in Figure 2.
The ROC analyses performed on the mild AD group
yielded 0.99 for the area under the curve (AUC) (95%
CI, 0. 99–1.00) for the MES-total score, with sensitivity
of 0.99 and specificity of 0.97, and 98% correct classifica-
tion rate when the cut-off was less than 62. The MMSE
had 0.985 AUC (95% CI, 0.97–0.99), with sensitivity of
0.91 and specificity of 0.98, and 95% correct classifica-
tion rate when the cut-off was less than 25. The AUC of
the MES-total score is significantly higher than that of
the MMSE (Z=2.866,P =0.0042). The ROC graphs are
presented in Figure 3.Figure 2 ROC curve of NC vs aMCI-md.
Figure 3 ROC curve of NC vs Mild AD.
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The results showed that the MES may be a suitable
screening method for MCI and mild dementia. First,
time was saved as the most involved cognitive domains
were evaluated selectively; second, the score range for
memory and executive function was large enough to
identify MCI; third, it was independent of pencil and
paper, and reading and writing skills were not required
of subjects. Hence, education was not a factor with the
MES score.
In order to reach our aim, much preliminary work
was carried out. With regard to the memory materials
in the neuropsychological tests, the sentence, rather
than word list, is more suitable for the illiterate and
low-educated people. Lengths of sentences and numbers
of trials and recalls were determined by careful consid-
eration and repeatable pilot studies. Second, as implicit
memory is relatively preserved for mild AD patients
[38], memory materials chosen were unfamiliar. Person
(Li Xiao-ming) and place names (He-xi town and Yong-
an county) were imaginary. Third, auditory memory
material appeared to be more sensitive than visual ma-
terial for the Chinese elderly [26]. Delayed recall of epi-
sodic memory may be the most sensitive predictor for
AD, but only long delay recall, easily producing floor
effects, was not applied to evaluate severity of memory
damage and cognitive change at follow-up. Accordingly,
in our study, the summation of immediate and delayed
recall performances was the indicator for the memory
factor.
For patients with AD, executive function was another
cognitive domain involved in addition to memoryfunction, and the initial damaged domain for FTLD and
VaD patients. In the beginning of the process of compil-
ing the MES, we searched for various executive memory
tests independent of pencil and paper in the literature
[35,39-41]. The initial tests included the Category Flu-
ency Test,the Object Figure Naming and Sorting Test,
the Conflicting Instructions Task, the Go/No Go Task,
the Sequential Movement Tasks, the Oral Symbol Digit
Modality Test, Stroop Color Words Test, the Similarities
Test, the Proverbs Test, the Wisconsin Card Sorting
Test, the California Cards Sorting Test, the Tower of
London or Tower of Hanoi, and the Paced Auditory Ser-
ial Addition Test. Preliminary application and verifica-
tion were undertaken. Considering the rate, reliability
and validity of accomplishment, we selected the Con-
flicting Instructions Task, the Go/No Go Task, the Se-
quential Movement Tasks and the Verbal Fluency Test
as the subtests of the MES-EX. The tests could be used
for the two usual components of executive function in-
cluding the set shift and dominant inhibition. The MES
ratio (MES-5R/MES-EX) may apply for distinguishing
between AD and FTLD or VaD. There is one point that
we should emphasize, namely, that the four subtests of
the MES-EX are similar to the four tests of the frontal
assessment battery( FAB) [41] in the meaning of the
tests, but the concrete operations, procedure and scoring
standard are different.
The MES was related to aging. Many studies have
shown that executive function may decrease with in-
creasing age [42,43]. Level of education was not related
to MES performance. In western countries, the educa-
tion level for the elderly is generally high, and the focus
of researchers may be the effects of age and gender on
neuropsychological tests. However, in a developing
country like China, illiterate persons remain a significant
proportion of the population. According to the sixth
population censuses in 2010, of the total population, the
proportion of persons with education exceeding univer-
sity level accounted for 8.7%, senior high school for
13.7%, junior high school for 37.9%, and primary school
for 26.2%, while the illiteracy rate was 13.5%. The num-
bers of elderly with low levels of education was therefore
expected to be large. As the result, it was necessary to
compile tests suitable for people with low education
levels. In our sample, there were quite a lot of persons
with low education levels, or even illiterate, and also
individuals with high education levels and university
careers. The statistical results showed that the MES was
independent of education and knowledge. As the subt-
ests were the items independent of reading and writing,
the MES may be used for cross-cultural comparison of
different countries.
At present, there have been few studies about the MCI
subtypes of single-domain and. multiple-domain mild
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show that multiple-domain MCI (particularly amnestic)
confers greater risk of progression to dementia than
single-domain MCI, even when examining multiple
domains of MCI [45-47]. Those with single-domain MCI
and naMCI (non-amnestic MCI) have a relatively high
rate of reversion to normal cognition [48,49]. Mitchell
et al. [50]discovered that of the multi-domain MCI
group, 59% progressed to dementia and only 5%
improved. By contrast, in pure aMCI, only 18% pro-
gressed and 41% improved by two-year follow-up. These
findings may simply reflect a threshold/definitional ef-
fect, in that multiple-domain impairment represents
more advanced disease than single-domain impairment
and is closer to the dementia threshold, that is, the out-
come of interest is very similar to the predictor. As a re-
sult, differentiation of MCI subtypes has been necessary.
The MES test, as a tool to identify single-domain and
multiple-domain subtypes at a given point, may be help-
ful for the prognosis of MCI.
Total time for MES administration and scoring
averages approximately seven minutes, similar to the
time for the MMSE or DemTect and notably less than
that of the MoCA and the seven minute neurocogni-
tive screening battery (which actually needs 12
minutes).
As a screening test, the content of items of the MES is
different from other common neuropsychological tests
such as the MMSE, the Mini-Cog, and the ADAS-cog
[51,52], and could be administered together with those
tests. As a part of the annual health check for the eld-
erly, the MES could also be performed alongside other
routine measurements (height, weight, and blood pres-
sure) as a measurement of objective cognitive function.
The MES would increase the probability of earlier diag-
nosis and improve ability to monitor change over time
and treatment response in clinic outpatients. The feasi-
bility of the MES as a follow-up tool has been validated
in the process.
Conclusions
The MES may be a highly sensitive and specific cogni-
tive screening tool that is valid, easy to administer, and
minimally time-consuming. It can be applied as a
screening tool for large epidemiological surveys. Because
the score range and gradient change of test difficulty are
large enough, it may be suitable to evaluate cognitive
changes during therapy for outpatients. Further longitu-
dinal studies will be undertaken to investigate some
issues, such as the follow-up value, discrimination of
aMCI and naMCI, the relationship of MES score and
MRI features (hippocampus or cerebral atrophy), and
cerebral spinal fluid biomarkers. Additionally, there are
some cognitive domains that the MES could notmeasure. Whether some atypical ADs, such as those
manifesting of language deficit or visual spatial im-
pairment, will miss being diagnosed, is worth further
investigation.Appendix 1: Memory and Executive Screening
(MES)
Q1. The rater should read out the following sentence
and have the subject repeat (Do not let the subject read
the sentence). [Li] [Xiao-Ming] has [two][gray][puppies],
and lives at [No. 58], [ He-xi][town], [Yong-an][county].
There are a total of 10 key points, they are the words in
the square brackets. Subject gets 1 point for each key
point he/she answers correctly. The subject does not
score a point if his/her answer is only partially correct
(e.g., Saying “Shao-Ming” instead of “Xiao-Ming”). The
subject is allowed to repeat the key points in reverse
orders (e.g., saying “Li Xiao-Ming’s two gray puppies are
gray”). Repeat the sentence two more times and write
down the subject’s answer.
Note: 1).Requires rater to read the sentence continu-
ously. Do not respond to any of the subject’s questions
in between. 2). After the third time recalling, inform the
subject “Please remember the sentence, I will ask you to
repeat it later.” 3). The subject does not need to learn
the third time if he/she answered all the key points cor-
rectly in the first or second time.
Q2. ”Please generate all the things you can think of
that can be used or seen in the kitchen”, count down 30
seconds and write down all the subject’s answers, even if
there are more than 10.
Q3. Conflicting Instructions: “When I tap twice, you
tap once, and when I tap once, you tap twice.” In order
for the subject to understand the rule, please demon-
strate: The practitioner taps once, and the subject should
tap twice; the practitioner taps twice, and the subject
should tap once. Every tap should be about 2 seconds.
Finish the series of number below: 1-1-2-1-2-2-2-1-1-2-
1-2-2-1-1. Score method: Mark the ones he/she tapped
wrong, minus 1 point for each mistake. Range score is
0–10.
Note: 1). The numbers should be tapped continuously
and equally. Finish the task in 30 seconds. 2). Make sure
the subject understands the rules completely before
starting. Once you begin, tap the numbers equally and
do not respond to any interference until the task is done.
3). Avoid suggesting to the subject whether to tap or
not. 4). The subject only scores when his/her finger
touches the table. The tap does not count if his/her fin-
ger stops half way. 5). To avoid hurting the subject’s fin-
ger while tapping, subject can also choose pounding the
table instead.
Q4 Short delayed recall: 4th time.
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http://www.biomedcentral.com/1471-2377/12/119Rater does not repeat the above sentence and asks
subject to recall the previous sentence that was learned
before.
Q5. Have the subject use his/her hand to imitate the
following action one hand at a time. Imitate every action
once.
Step 1: Subject uses dominant hand to imitate the ac-
tion, and complete with single hand. Subject scores 2
points if correctly done.
Step 2: If the action is not imitated correctly, the prac-
titioner can repeat the action one more time. Subject
scores 1 point if correctly done.
Step 3: Subject uses non-dominant hand to imitate the
action without the practitioner demonstrating with non-
dominant hand. Subject scores 2 points if correctly
done.
Step 4: If the action is not imitated correctly with sub-
ject’s non-dominant hand, the practitioner can repeat
the action one more time with non-dominant hand. Sub-
ject scores 1 point if correctly done.
Note the similarity and sequence of the shape of
gesture in every movement. 2 points for each action
that is completely correct first imitation, and one
point if a second repetition is needed (no third
repetition).
1) Use thumb to touch other four fingertips in order
2) Put thumb between index finger and middle finger–
scissor shape
3) Put wrist on same side eye(Telescope-like gesture)–
same side ear(Listen-like gesture)–mouth(Drink-like
gesture)
4) Do a cross (touch forehead, chest, contralateral
shoulder and ipsilateral shoulder by order)
5) Luria action. Instructions: Make a fist, slice down
with the edge of your palm, then close your fingers
and put the back of your hand flat on the table.
Q6. Inhibitory Control Test (Go/No-go test): “When I
tap once, you tap once, and when I tap twice, you don’t
tap.” In order for the subject to understand the rule,
please demonstrate: The practitioner taps once, and the
subject should also tap once; the practitioner taps twice,
and the subject should not tap. Start the test after the
subject understands the rule. If there are errors in the
process, do not remind the subject. Every tap should be
about 2 seconds. Finish the series of number below: 1-2-
1-2-1-1-2-2-1-1-2-1-2-1-2. [Score method] Mark the
ones he/she tapped wrong, minus 1 point for each mis-
take. Range score is 0–10.
Note: The numbers should be tapped continuously
and equally. Do not respond to any of the subject’s ques-
tions in between. Finish the task in 30 seconds.
Q7 Long delayed recall: (5th time).Ask the subject to once again recall the sentence that
was learned before.
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